Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination

Journal of Immunological Methods

Volumn 353, Issue 1-2, 2010, Pages 20-23

  Yu, Liping ^a   Liu, Yu ^b   Miao, Dongmei ^a   Wenzlau, Janet ^a   Davidson, Howard ^a   Hutton, John ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Autoantibodies; Autoantigen; Diabetes; Radioassay

Indexed keywords

ARGININE; AUTOANTIBODY; AUTOANTIGEN; CHIMERIC PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULINOMA ASSOCIATED PROTEIN 2; INSULINOMA ASSOCIATED PROTEIN 2 ANTIBODY; TRYPTOPHAN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8; ZINC TRANSPORTER 8 ANTIBODY;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; DIABETES MELLITUS; GENE CONSTRUCT; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; INFANT; ISLETS OF LANGERHANS; POLYMORPHISM, GENETIC; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77649272941     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.12.004     Document Type: Article

References (8)

1. Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., Gale E.A.M. Prediction on IDDM in the general population; strategies based on combinations of autoantibody markers. Diabetes 1997, 46:1701.
2. Greenbaum C.J., Sears K.L., Kahn S.E., Palmer J.P. Relationship of ß-cell function and autoantibodies to progression and non-progression of subclinical type 1 diabetes. Diabetes 1999, 48:170.
3. Krischer J.P., Cuthbertson D.D., Yu L., Orban T., Maclaren N., Jackson R., Winter W.E., Schatz D.A., Palmer J.P., Eisenbarth G.S. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:103. DPT-1 Study Group.
4. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase P.H., Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45:926.
5. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., Hutton John C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. 2007, 104:17040.
6. Wenzlau, J.M., Moura, O., Sarkar, S.A., Yu, L., Rewers, M., Eisenbarth, G.S., Davidson, H.W., Hutton, J.C., 2008. S1C30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann. N. Y. Acad. Sci. 1150, 256.
7. Wenzlau J.M., Liu Y., Yu L., Moura O., Fowler K.T., Rangasamy S., Walters J., Eisenbarth G.S., Davidson H.W., Hutton J.C. A common non-synonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008, 57:2693.
8. Yu L., Rewers M., Gianani R., Kawasaki E., Zhang Y., Verge C., Chase P., Klingensmith G., Erlich H., Norris J., Eisenbarth G.S. Anti-islet autoantibodies develop sequentially rather than simultaneously. J. Clin. Endocrinol. Metab. 1996, 81:4264.